Effects of Edaravone on Cerebral Injury in Patients Undergoing Cardiac Valve Replacement

JIANG Jie,CHEN Yi-jiang,CHEN Liang,WU Yan-hu,ZHANG Bin

DOI: https://doi.org/10.3969/j.issn.1007-4368.2006.07.027

2006-01-01

Abstract:Objective: To investigate the effects of the free radical scavenger edaravone on cerebral injury and the possible mechanisms during cardiac valve replacement.Methods: Thirty patients undergoing mitral or aortic valve replacement(MVR or AVR) with CPB were randomly divided into two groups: control group and experiment group.In experiment group 0.5mg/kg edaravone was given by intravenous injection at 5 min after anesthesia induction and 0.5mg/kg edaravone was given at 5 min before aortic declamping.Blood samples were collected from intrajugular vein for determination of serum levels of S-100 protein,neuron-specific enolase(NSE),malondialdehyde(MDA),super oxide dismutase(SOD) activity and total antioxidant capacity(TAOC) at six time-points:5 min after anesthesia induction(T1),5 min after aortic declamping(T2),1h(T3),2h(T4),6h(T5),24h(T6) after aortic declamping.Results: The serum levels of S-100 protein,NSE?MDA and TAOC were significantly increased after aortic declamping(T2-5) compared to the baseline values before CPB(T1)(P 0.01).The serum levels of NES,S-100 protein and MDA after aortic declamping(T2-5) were significantly lower in the experiment group than those in the control group(P 0.05 or 0.01).SOD activity and TAOC after aortic declamping(T2-5) were significantly higher in the experiment group than those in the control group(P 0.05 or 0.01).Conclusion: Edaravone can attenuate cerebral injury during cardiac valve replacement with CPB.The possible mechanisms are that edaravone can protect the activity of SOD,increase the activity of TAOC and decrease the production of MDA in order to reduce cerebral inchemia-reperfusion injury.